Overactive gene appears to play a role
ovarian cancer
OMRF receives new grants to study blood clotting, ovarian cancer
The National Institutes of Health grants total nearly $2.1 million.
Innovative researchers join Oklahoma cancer team at OMRF and OU
New researchers are focused on recurring breast cancer.
